Repligen Corp share price logo

Repligen Corp Share Price

NASDAQ: RGEN

Mid Cap

$119.77

+6.03

(+5.30%)

as on

Repligen Corp Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $112.84
    $120.16
    downward going graph

    5.79%

    Downside

    0.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $102.97
    $182.52
    downward going graph

    14.03%

    Downside

    52.39%

    Upside

    downward going graph

Repligen Corp share price movements today

Previous Close
$113.74
Open
$113.56
Volume
1.0M
Day's Low - High
$112.84 - $120.16
52 Week Low - High
$102.97 - $182.52

Repligen Corp Historical Returns

1 Month Return
-8.53 %
3 Month Return
-9.79 %
1 Year Return
-18.76 %
3 Year Return
-48.61 %
5 Year Return
-22.7 %

Repligen Corp Stock Fundamentals & Key Indicators

Check Repligen Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.4B

EPS (TTM)

1.6842

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.60%

PE Ratio (TTM)

-4441.34

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

2.59

EBITDA

126.5M

Revenue (TTM)

674.0M

Profit Margin

-2.05%

Return On Equity TTM

8781000.00%

Repligen Corp Stock Valuation

Track how Repligen Corp P/E has moved over time to understand its valuation trends.

Repligen Corp in the last 5 years

  • Overview

  • Trends

Lowest (46.25x)

June 30, 2022

Today (-4441.34x)

September 16, 2025

Industry (10.13x)

September 16, 2025

Highest (154.47x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -4441.34x

Repligen Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Repligen Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$6.4B-22.7%-4441.34-2.05%
BUY$161.2B88.31%62.928.51%
BUY$39.7B55.8%28.427.22%
BUY$38.9B31.65%36.2510.70%
BUY$18.5B-8.44%37.8716.48%

Stock Returns calculator for Repligen Corp Stock including INR - Dollar returns

The Repligen Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Repligen Corp investment value today

Current value as on today

₹90,417

Returns

₹9,583

(-9.58%)

Returns from Repligen Corp Stock

₹14,450 (-14.45%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Repligen Corp Stock

Based on 19 analysts

BUY

78.95%

Buy

21.05%

Hold

0.00%

Sell

Based on 19 analysts, 78.95% of analysts recommend a 'BUY' rating for Repligen Corp. Average target price of $179.22

Repligen Corp Share Price Target

Get share price movements and forecasts by analysts on Repligen Corp.

What analysts predicted

33.17%UPSIDE

Target Price

$179.22

Current Price

$119.77

Analyzed by

19 Analysts

Target

$179.22

Repligen Corp target price $179.22, a slight upside of 33.17% compared to current price of $119.77. According to 19 analysts rating.

Repligen Corp Stock's Interest Amongst Investors

Search interest for Repligen Corp Stock has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-65% versus previous 30 day period

Repligen Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
182
159
141
155
151
154
154
167
169
182
Gross Profit
100
79
36
67
74
68
77
75
90
82
Operating Income
31
19
4
0
2
1
-7
-36
6
13
EBITDA
47
37
32
19
18
27
21
33
36
44
Interest Expense
0
0
0
7
4
5
5
5
5
5
Depreciation
15
15
19
17
16
16
17
35
23
24
Income Before Tax
36
25
11
-8
2
5
-1
-38
7
18
Income Tax Expense
7
5
-6
16
0
1
0
-4
2
3
Net Income
28
20
18
-25
2
3
0
-33
5
14
Net Profit Margin
15.78%
12.61%
12.87%
-16.37%
1.38%
2.16%
-0.42%
-20.21%
3.45%
8.15%

Repligen Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
83
104
141
194
270
366
670
801
638
634
Gross Profit
48
57
74
108
151
209
391
455
284
274
Operating Income
13
15
14
25
14
42
133
133
54
-35
EBITDA
22
24
24
41
58
101
211
246
124
82
Interest Expense
0
3
6
6
9
12
12
2
10
22
Depreciation
-
-
10
15
20
27
38
50
65
86
Income Before Tax
13
11
7
21
26
59
153
219
64
-27
Income Tax Expense
4
0
-21
4
4
0
25
33
22
-1
Net Income
9
11
28
16
21
59
128
185
41
-25
Net Profit Margin
11.19%
11.17%
20.07%
8.56%
7.92%
16.36%
19.13%
23.20%
6.51%
-4.02%

Repligen Corp Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
20
18
-25
2
3
0
-33
5
14
Operating Cash Flow
34
39
29
44
42
49
39
15
28
Investing Cash Flow
64
-8
-169
-8
-
-5
-64
-74
-7
Financing Cash Flow
-8
0
268
-8
-5
-69
1
-5
-10
Change in Cash
87
27
120
29
28
-25
-26
-60
11

Repligen Corp Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
11
28
16
21
59
128
185
41
-25
Operating Cash Flow
7
17
32
67
62
119
172
113
175
Investing Cash Flow
-49
-98
-14
-205
-201
-221
-233
-
-86
Financing Cash Flow
112
129
3
484
305
0
-13
248
-82
Change in Cash
68
51
20
343
179
-113
-80
227
6

Global Institutional Holdings in Repligen Corp

Funds
Holdings
T. Rowe Price Associates, Inc.
13.45%
BlackRock Inc
12.12%
Vanguard Group Inc
9.03%
State Street Corp
3%
Amvescap Plc.
2.98%

Insights on Repligen Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 151.34M → 182.36M (in $), with an average increase of 3.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -33.86M → 14.86M (in $), with an average increase of 370.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Intuitive Surgical, Inc. has given 21.6% return, outperforming this stock by 70.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Resmed Inc. has given 8.1% return, outperforming this stock by 24.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RGEN stock has moved down by -5.4%

About Repligen Corp

repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opus™ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen’s corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.
OrganisationRepligen Corp
HeadquartersBuilding 1, Waltham, MA, United States, 02453
IndustryHealth Technology
CEOMr. Olivier Loeillot
E-voting on sharesClick here to vote

Key Management of Repligen Corp

Name

Title

Mr. George A. Scott

Vice President of Legal

Mr. Olivier Loeillot

President, CEO & Director

Mr. Jason K. Garland

CFO & Chief Compliance Officer

Mr. James R. Bylund

Chief Operating Officer

Mr. Keith Lee Robinson

Chief Information Officer

Mr. Neil Whitfield

Senior Vice President of Sales

Mr. Anthony J. Hunt

Executive Chair

Mr. Ralf Kuriyel

Senior Vice President of Research & Development

Ms. Violetta Hughes

Chief Accounting Officer

Ms. Sondra S. Newman

Global Head of Investor Relations

FAQs

What is Repligen Corp share price today?

Repligen Corp share price today is $119.77 as on at the close of the market. Repligen Corp share today touched a day high of $120.16 and a low of $112.84.

What is the 52 week high and 52 week low for Repligen Corp share?

Repligen Corp share touched a 52 week high of $182.52 on and a 52 week low of $102.97 on . Repligen Corp stock price today i.e. is closed at $119.77,which is 34.38% down from its 52 week high and 16.32% up from its 52 week low.

What is Repligen Corp's market capitalisation today?

Repligen Corp market capitalisation is $0.01T as on .

How to invest in Repligen Corp Stock (RGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Repligen Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Repligen Corp Shares that will get you 0.0125 shares as per Repligen Corp share price of $119.77 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Repligen Corp Stock (RGEN) from India?

Indian investors can start investing in Repligen Corp (RGEN) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Repligen Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Repligen Corp share’s latest price of $119.77 as on September 17, 2025 at 1:29 am IST, you will get 0.0835 shares of Repligen Corp. Learn more about fractional shares .

What are the returns that Repligen Corp has given to Indian investors in the last 5 years?

Repligen Corp stock has given -22.7% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?